Abzu and ADViRNA are partnering on siRNA therapeutics development Abzu (Copenhagen) and ADViRNA (Worcester, MA) are joining forces to develop novel siRNA therapeutics. This collaboration combines Abzu's AI-driven siRNA design platform with ADViRNA's wet-lab expertise from sequence design through in vivo validation.ADViRNA is a boutique U.S.-based CRO headquartered in Worcester, Massachusetts, specializing in the design, synthesis, and validation of oligonucleotide therapeutics.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Abzu
Contact Abzu, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack